Long-Chain Acylcarnitines and Monounsaturated Fatty Acids Discriminate Heart Failure Patients According to Pulmonary Hypertension Status

Long-Chain Acylcarnitines and Monounsaturated Fatty Acids Discriminate Heart Failure Patients According to Pulmonary Hypertension Status

Defects in fatty acid (FA) utilization have been well described in group 1 pulmonary hypertension (PH) and in heart failure (HF), yet poorly studied in group 2 PH. This study was to assess whether the metabolomic profile of patients with pulmonary hypertension (PH) due HF, classified as group 2 PH,...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Maxime Tremblay-Gravel, Annik Fortier, Cantin Baron, Chloé David, Pamela Mehanna, Anique Ducharme, Julie Hussin, Qinghua Hu, Jean-Claude Tardif, Christine Des Rosiers, Jocelyn Dupuis, Matthieu Ruiz
Materialtyp: Artikel
Språk:English
Publicerad: MDPI AG 2021-03-01
Serie:Metabolites
Ämnen:
acylcarnitines
fatty acids
heart failure
type 2 pulmonary hypertension
Länkar:https://www.mdpi.com/2218-1989/11/4/196

Internet

https://www.mdpi.com/2218-1989/11/4/196

Liknande verk